DEERLAND ENZYMES – Trademark Portfolio
Entity Type: 03
DEERLAND ENZYMES holds 26 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 24 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 17 trademarks are registered. Notable registered marks include BIOCORE, ISOLASE, CERECALASE, NATTOZIMES, and N·ZIMES PA. The owner is based in KENNESAW, GA.
3800 COBB INTERNATIONAL BLVD.
KENNESAW, GA 30152
Showing of trademarks Trademarks
Trademark Classifications
DEERLAND ENZYMES's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does DEERLAND ENZYMES have?
DEERLAND ENZYMES has 26 U.S. trademarks filed with the USPTO. Of these, 17 registered, 9 cancelled.
What trademark classes does DEERLAND ENZYMES file in?
DEERLAND ENZYMES files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 44 (Medical Services), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are DEERLAND ENZYMES's most well-known trademarks?
DEERLAND ENZYMES's registered trademark portfolio includes well-known marks such as BIOCORE, ISOLASE, CERECALASE, NATTOZIMES, and N·ZIMES PA. These are among 17 currently registered trademarks in the portfolio.
What is DEERLAND ENZYMES's trademark registration success rate?
DEERLAND ENZYMES has a 65% trademark registration rate, with 17 out of 26 resolved applications resulting in successful registration. Currently, 0 applications are pending review.